###begin article-title 0
###xml 84 101 <span type="species:ncbi:11103">Hepatitis C virus</span>
The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry
###end article-title 0
###begin title 1
Background
###end title 1
###begin p 2
###xml 422 433 422 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 69 86 <span type="species:ncbi:11103">hepatitis C virus</span>
###xml 88 91 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 177 180 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 370 373 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Three percent of the world's population is chronically infected with hepatitis C virus (HCV) and thus at risk of developing liver cancer. Although precise mechanisms regulating HCV entry into hepatic cells are still unknown, several cell surface proteins have been identified as entry factors for this virus. Among these molecules, the tetraspanin CD81 is essential for HCV entry. Interestingly, CD81 is also required for Plasmodium infection. A major characteristic of tetraspanins is their ability to interact with each other and other transmembrane proteins to build tetraspanin-enriched microdomains (TEM).
###end p 2
###begin title 3
Results
###end title 3
###begin p 4
###xml 299 300 299 300 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 384 385 384 385 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 28 33 <span type="species:ncbi:9606">human</span>
###xml 124 127 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 155 160 <span type="species:ncbi:10090">mouse</span>
###xml 352 355 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 464 467 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 530 533 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 698 701 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In our study, we describe a human hepatoma Huh-7 cell clone (Huh-7w7) which has lost CD81 expression and can be infected by HCV when human CD81 (hCD81) or mouse CD81 (mCD81) is ectopically expressed. We took advantage of these permissive cells expressing mCD81 and the previously described MT81/MT81w mAbs to analyze the role of TEM-associated CD81 in HCV infection. Importantly, MT81w antibody, which only recognizes TEM-associated mCD81, did not strongly affect HCV infection. Furthermore, cholesterol depletion, which inhibits HCV infection and reduces total cell surface expression of CD81, did not affect TEM-associated CD81 levels. In addition, sphingomyelinase treatment, which also reduces HCV infection and cell surface expression of total CD81, raised TEM-associated CD81 levels.
###end p 4
###begin title 5
Conclusion
###end title 5
###begin p 6
###xml 15 26 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 125 128 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In contrast to Plasmodium infection, our data show that association of CD81 with TEM is not essential for the early steps of HCV life cycle, indicating that these two pathogens, while using the same molecules, invade their host by different mechanisms.
###end p 6
###begin title 7
Background
###end title 7
###begin p 8
###xml 84 85 84 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 363 364 363 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 850 851 850 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 852 853 852 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 987 988 987 988 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 26 32 <span type="species:ncbi:9606">people</span>
###xml 59 70 <span type="species:ncbi:11103">Hepatitis C</span>
###xml 78 81 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 367 370 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 547 550 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 672 675 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 769 772 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 951 954 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1062 1065 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1129 1132 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Approximately 130 million people are infected worldwide by Hepatitis C Virus (HCV) [1]. Almost 80% of infected patients develop a chronic hepatitis that can in the long term evolve either to liver cirrhosis or hepatocellular carcinoma. Unfortunately, no vaccine is currently available to prevent new infections and the current treatments are not fully efficient [2]. HCV is an enveloped RNA virus mainly targeting liver cells by a mechanism that has yet to be elucidated. For a long time, it has been difficult to study the different steps of the HCV life cycle because of the difficulties in propagating this virus in cell culture. However, a major step in investigating HCV entry was achieved in the development of pseudotyped particles (HCVpp), consisting of native HCV envelope glycoproteins, E1 and E2, assembled onto retroviral core particles [3-5]. More recently, the development of a cell culture system allowing an efficient amplification of HCV (HCVcc) has also been reported [6-8]. This cell culture system allows the study of the whole life cycle of HCV and, together with HCVpp, also permits the characterization of HCV entry mechanisms.
###end p 8
###begin p 9
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 310 312 310 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 574 576 574 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 771 773 771 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 842 851 842 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro </italic>
###xml 1038 1040 1038 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 1484 1486 1484 1486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 154 157 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 258 261 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 737 740 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 871 877 <span type="species:ncbi:10090">murine</span>
###xml 917 920 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1287 1290 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1479 1482 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Although the early steps of viral entry have yet to be elucidated, accumulated data suggest several cell surface-expressed molecules as entry factors for HCV (reviewed in [9]). Among these molecules, the tetraspanin CD81 has been shown to play a key role in HCV entry, acting during a post-attachment step [10,11]. Like all members of the tetraspanin family, CD81 is composed of four transmembrane domains, a small extracellular loop (SEL) and a large extracellular loop (LEL), which contains a conserved CCG amino acid motif involved in the formation of disulfide bridges [12]. The CD81 LEL is the critical region for the interaction with the E2 envelope glycoprotein and for virus entry. The role of CD81 in the species restriction of HCV has been extensively studied [13-18], and it has been recently shown that in spite of the absence of in vitro interaction between murine CD81 (mCD81) LEL and a soluble form of HCV E2, the ectopic expression of mCD81 in HepG2 cells restored permissivity to HCVpp and, in a lesser extent, to HCVcc [15]. These results suggest that CD81 contributes to, but alone does not define, the species restriction and additional cellular factors are likely involved. Moreover, we have recently shown that EWI-2wint, a new partner of CD81, is able to modulate HCV entry in target cells suggesting that, in addition to the presence of specific entry factors in the hepatocytes, the absence of a specific inhibitor may contribute to the hepatotropism of HCV [19].
###end p 9
###begin p 10
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 465 467 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 468 470 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 641 643 641 643 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 649 660 649 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 735 746 735 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 801 803 801 803 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 931 932 931 932 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1002 1013 1002 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1054 1065 1054 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 636 639 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 884 889 <span type="species:ncbi:10090">mouse</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1069 1072 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1161 1164 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Members of the tetraspanin family organize and regroup their associated transmembrane proteins and are involved in various functions such as cell morphology, motility, fusion and signalling [12,20]. A major characteristic of tetraspanins is their ability to interact with each other and with other transmembrane proteins, thus building multi-molecular membrane complexes, collectively referred to as the tetraspanin enriched microdomains (TEM) or tetraspanin webs [21,22]. Membrane cholesterol contributes to the organization of these domains on the surface of live cells [23]. Cholesterol is also critical to many pathogens, including HCV [24] and Plasmodium infection [23]. Interestingly, it has been shown that CD81 is required for Plasmodium sporozoite entry and differentiation into hepatocytes [25,26]. Using a monoclonal antibody (mAb) that specifically recognizes a subset of mouse CD81 molecules associated with TEMs (MT81w), Silvie et al. have defined the role of TEM-associated CD81 in mice Plasmodium infection [23]. The similarities between Plasmodium and HCV liver infections indicate the importance of studying the role of TEM-associated CD81 in HCV infection.
###end p 10
###begin p 11
###xml 137 140 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 310 313 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 372 375 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In our study, infection of Huh-7 target cells with highly infectious HCVcc particles allowed us to isolate a cellular clone resistant to HCV infection which has lost CD81 expression (Huh-7w7 cells). We then took advantage of the emergence of these CD81-deficient cells to analyze the functionality of mCD81 in HCV infection and to study the role of TEM-associated CD81 in HCV infection.
###end p 11
###begin title 12
Results
###end title 12
###begin title 13
###xml 39 42 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Generation of Huh-7 cells resistant to HCV infection
###end title 13
###begin p 14
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 684 686 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1A</xref>
###xml 940 942 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 1146 1148 1142 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1B</xref>
###xml 42 45 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 355 358 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 773 776 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In a previous study, we have shown that a HCV JFH-1 full-length RNA genome encoding mutations in the capsid and E2 sequences (JFH-1/CS-N6) releases highly infectious HCVcc particles which display a marked cytopathic effect on target cells [27]. Infection of Huh-7 cells with these particles led to the selection of few living cells that were resistant to HCV infection. In order to analyze the capacity of these cells to resist to HCVcc infection, they were amplified and treated with interferon alpha to eliminate any potential remaining virus. This cell population, called Resistant 1 (R1), displayed reduced levels of JFH-1 HCVcc infection compared to parental Huh-7 cells (Figure 1A). In parallel, we infected the R1 cell population with retroviral particles harboring HCV envelope glycoproteins of genotypes 1a or 2a (HCVpp-1a or HCVpp-2a, respectively) and found reduced levels of HCVpp infection in comparison to Huh-7 cells (Figure 1B). Both cell lines were not infected by particles devoid of envelope proteins (data not shown) and were equally infected with the positive control VSVpp, which infects virtually all type of cells (Figure 1B).
###end p 14
###begin p 15
###xml 0 81 0 81 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ectopic expression of CD81 in HCV-resistant Huh-7 cells restores HCV permissivity</bold>
###xml 83 84 83 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 253 254 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 397 398 397 398 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 482 490 482 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
###xml 598 599 598 599 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 781 782 781 782 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 995 996 995 996 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1309 1310 1309 1310 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">G</bold>
###xml 1340 1341 1340 1341 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</bold>
###xml 1582 1584 1582 1584 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 30 33 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 65 68 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 304 307 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1427 1456 <span type="species:ncbi:11767">feline endogenous virus RD114</span>
Ectopic expression of CD81 in HCV-resistant Huh-7 cells restores HCV permissivity. A, Huh-7 cells and R1 cell population infected with JFH-1 HCVcc were processed for double-label immunofluorescence for capsid protein (green) and nuclei (blue, Hoechst). B, Cells were infected with virus pseudotyped with HCV envelope proteins from 1a (HCVpp 1a) or 2a (HCVpp 2a) or VSV G envelope protein (VSVpp). C, Huh-7 cells and R1 individual cellular clones were infected with HCVcc expressing Renilla luciferase. In parallel, Huh-7 cells and some of the clones were infected with HCVpp 1a, HCVpp 2a or VSVpp (D). Results are presented as relative percentages to HCVcc (C) and HCVpp (D) infectivity on Huh-7 cells. HCVpp infections (D) were also normalized to VSVpp infections on Huh-7 cells. E, Surface biotinylated cell lysates were immunoprecipitated with anti-CD81 (5A6), anti-SR-BI (NB400-104H3) or anti-CLDN-1 (JAY.8) mAbs. Proteins were revealed by Western blotting with HRP-conjugated streptavidin. F, Flow cytometry analysis of CD81 cell surface expression. Cells were stained using an anti-hCD81 (1.3.3.22, left panel) or an anti-mCD81 (MT81, right panel), and secondary antibodies conjugated with PE. Ctrl corresponds to Huh-7 cells stained only with secondary antibodies. Cell lines were infected with HCVcc (G) and in parallel with HCVpp (H) generated with envelope proteins from different genotypes or virus pseudotyped with feline endogenous virus RD114 glycoprotein (Rd114pp). Results are presented as relative percentages to HCVcc (G) and HCVpp (H) infectivity on Huh-7 cells. P < 0.05 as calculated by the Mann-Whitney's test; *, statistically not significant difference in HCVpp entry compared to entry into Huh-7 cells.
###end p 15
###begin p 16
###xml 197 199 197 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1C</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1D</xref>
###xml 47 50 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 591 594 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
To further analyze this cellular resistance to HCV infection, cellular clones were isolated by limiting dilution and their sensitivity to HCVcc and HCVpp infection was analyzed. As shown in Figure 1C, several clones were resistant to infection (clones 3, 7, 8, 10, 12 and 14) while others exhibited some susceptibility to HCVcc (clones 1, 2, 4, 5, 6 and 16), but greatly reduced when compared to the parental Huh-7 cells. Interestingly, analysis of the sensitivity of several clones to HCVpp infection showed similar reduced infectivity levels (Figure 1D), indicating that the entry step of HCV life cycle is affected in these cells. The only major difference was observed for clone 6, which was barely permissive for JFH-1 infection but highly permissive for HCVpp, suggesting that replication or assembly of HCVcc is likely affected in these cells.
###end p 16
###begin title 17
###xml 22 27 <span type="species:ncbi:9606">human</span>
###xml 32 37 <span type="species:ncbi:10090">mouse</span>
###xml 71 74 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Ectopic expression of human and mouse CD81 in resistant cells restores HCV permissivity
###end title 17
###begin p 18
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 413 415 413 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1E</xref>
###xml 4 7 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 927 930 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The HCV entry stage is a multistep process involving several cellular factors (reviewed in [9]). Among these molecules, the tetraspanin CD81, the Scavenger Receptor class B type I (SR-BI), and the tight junction protein claudin 1 (CLDN-1) play key roles. Since the absence of one of these molecules might explain the differences in infectivity of the R1 cell clones, their expression levels were examined (Figure 1E). Experiments of surface biotinylation followed by immunoprecipitations with specific mAbs showed that the cell surface expression levels of SR-BI and CLDN-1 were similar in each clone, whereas CD81 expression differed among the clones. CD81 cellular expression levels in R1 cell clones were also tested by anti-CD81 western-blotting over total cell lysates and similar results were obtained (data not shown). Interestingly, non permissive R1 cell clones were also negative for CD81 expression, indicating that HCV entry defect observed in clones 3, 7, 8, 10, 12 and 14 is likely due to the absence of CD81 expression.
###end p 18
###begin p 19
###xml 393 395 393 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1F</xref>
###xml 397 407 397 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">left panel</bold>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1F</xref>
###xml 441 452 441 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</bold>
###xml 708 710 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1F</xref>
###xml 712 723 712 723 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panel</bold>
###xml 167 172 <span type="species:ncbi:9606">human</span>
###xml 187 192 <span type="species:ncbi:10090">mouse</span>
###xml 814 819 <span type="species:ncbi:10090">mouse</span>
To confirm our hypothesis, we ectopically expressed CD81 in one of the non-permissive Huh-7 R1 cell clones (clone 7) that we called Huh-7w7 cells. Plasmids expressing human CD81 (hCD81), mouse CD81 (mCD81) or empty expression vector (pcDNA3.1) were stably transfected in Huh-7w7 cells. The CD81 expression level was next controlled by flow cytometry analysis using 1.3.3.22 anti-hCD81 (Figure 1F, left panel) and MT81 anti-mCD81 (Figure 1F, right panel) mAbs. Cell surface expression of hCD81 in Huh-7w7/hCD81 cells was higher than in parental Huh-7 cells, whereas no hCD81 expression was detectable in Huh-7w7/pcDNA3.1 and Huh-7w7/mCD81 cells. mCD81 was also highly expressed in Huh-7w7/mCD81 cells (Figure 1F, right panel) and expression level was comparable with the one of Hepa1.6 cells that naturally express mouse CD81 (data not shown). Huh-7 cells and the complemented Huh-7w7 populations displayed similar expression levels of the control tetraspanin CD151 (data not shown).
###end p 19
###begin p 20
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1G</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1H</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1H</xref>
###xml 788 790 788 790 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1F</xref>
###xml 883 885 883 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 166 169 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 402 405 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 516 519 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
We next tested the sensitivity of the different cell lines to HCVcc and HCVpp infection. Control cells expressing the empty vector pcDNA3.1 were totally resistant to HCV infection (Figures 1G and 1H). In contrast, Huh-7w7/hCD81 cells were equally or slightly more infected by HCVpp than parental Huh-7 cells (Figure 1H). Thus, ectopic expression of hCD81 fully restores permissivity to HCVpp harboring HCV envelope glycoproteins from different genotypes indicating that CD81 expression is likely the only defect for HCV entry in Huh-7w7 cells. However, the level of infectivity of Huh-7w7/hCD81 cells by HCVcc was 50%, as compared to the one of Huh-7 cells, indicating that despite being highly expressed, hCD81 did not fully restore permissivity to HCVcc. Overexpression of CD81 (Figure 1F) in Huh-7w7/hCD81 cells may lead CD81 to oligomerize, as shown for CD9 another tetraspanin [28], in less permissive CD81 molecules to HCVcc infection. The entry efficiency of HCVpp will not be affected in this context but only driven by CD81 expression levels. It has to be noted that differences in HCVcc and HCVpp entries have already been shown [29].
###end p 20
###begin p 21
###xml 122 124 122 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1G</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1H</xref>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 558 560 558 560 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 85 88 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Interestingly, ectopic expression of mCD81 in Huh-7w7 cells was also able to restore HCV permissivity. As shown in Figure 1G, the level of permissivity to HCVcc of Huh-7w7/mCD81 cells was 20% of the one of parental Huh-7 cells. In addition, permissivity of Huh-7w7/mCD81 cells to HCVpp bearing glycoproteins from different genotypes was analyzed and showed that mCD81 supports infection with HCVpp from genotypes 2a and 4, with 29% and 19% of level of infectivity respectively, as compared to the one of Huh-7 cells (Figure 1H). In contrast to Flint et al. [15], we did not observe any significant infectivity for HCVpp harboring glycoproteins from genotypes 1a and 1b.
###end p 21
###begin p 22
###xml 161 162 161 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">2</xref>
###xml 66 69 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 582 585 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
It is worth noting that the sensitivity of Huh-7w7/mCD81 cells to HCV infection is solely due to the expression of mCD81 since anti-hCD81 mAbs (1.3.3.22; Figure 2 and 5A6; not shown) efficiently inhibited HCVcc and HCVpp infection of Huh-7 and Huh-7w7/hCD81 cells, but did not significantly affect the infectivity of Huh-7w7/mCD81 cells. These results indicate that no residual expression of hCD81 is responsible for permissivity since in such a case infection would be fully inhibited by the anti-hCD81 mAbs. Control experiment performed with irrelevant antibodies did not inhibit HCV infectivity (data not shown).
###end p 22
###begin p 23
###xml 0 94 0 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Anti-hCD81 mAb inhibits HCV infection of hCD81 expressing cells but not of Huh-7w7/mCD81 cells</bold>
###xml 365 367 364 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 24 27 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Anti-hCD81 mAb inhibits HCV infection of hCD81 expressing cells but not of Huh-7w7/mCD81 cells. HCVcc (upper panel) and HCVpp 2a (lower panel) infections of cell lines were performed in absence (white histograms) or presence (black histograms) of 1.3.3.22 anti-hCD81 mAb (3 mug/ml). At 2 days post-infection, cells were lysed and processed as described in methods. P < 0.05 as calculated by the Mann-Whitney's test; *, statistically not significant difference in HCVcc infectivity compared to infectivity in absence of antibodies.
###end p 23
###begin p 24
###xml 41 44 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 230 233 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Taken together, these data indicate that HCV infection is directly related to CD81 expression in Huh-7w7 cells. Most importantly, mCD81 in the context of such human hepatocytes is able to some extent to mimic the role of hCD81 in HCV entry and likely interacts in a similar way with cellular factors.
###end p 24
###begin title 25
###xml 31 34 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Role of TEM-associated CD81 in HCV entry
###end title 25
###begin p 26
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 144 145 144 145 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 436 437 436 437 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 572 594 572 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium falciparum </italic>
###xml 613 631 613 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium yoelii </italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 657 658 657 658 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 676 681 676 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 754 765 754 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 787 789 787 789 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1019 1020 1019 1020 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 181 186 <span type="species:ncbi:10090">mouse</span>
###xml 558 563 <span type="species:ncbi:9606">human</span>
###xml 572 593 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 613 630 <span type="species:ncbi:5861">Plasmodium yoelii</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
###xml 1088 1091 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Tetraspanins associate extensively with each other and other membrane proteins to form the TEMs. Recently, Silvie et al. have described the MT81w mAb, which specifically recognizes mouse CD81 associated with other tetraspanins. This is evidenced by the lack of recognition of CD81 after cell lysis with detergents that do not preserve tetraspanin-tetraspanin interactions, and by the complete removal of the CD81 pool recognized by MT81w following immunodepletion of tetraspanin complexes [23]. CD81 is required for invasion of hepatocytes by sporozoites of human malaria Plasmodium falciparum and rodent malaria Plasmodium yoelii parasites [26]. Using MT81w antibody, Silvie et al. have shown that the subset of CD81 associated with TEMs contributes to Plasmodium sporozoite infection [23]. Such an antibody preferentially recognizing human CD81 associated with TEMs is not available. However, since Huh-7w7/mCD81 cells are susceptible to HCVcc and HCVpp-2a infection, we next took advantage of this model and the MT81w mAb to study the role of TEM-associated CD81 in the early steps of HCV life cycle.
###end p 26
###begin p 27
###xml 14 15 14 15 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3A</xref>
###xml 225 226 225 226 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 478 480 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 541 542 539 540 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 633 634 631 632 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 945 947 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 969 971 967 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3B</xref>
###xml 1084 1085 1082 1083 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1390 1391 1388 1389 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1397 1399 1395 1397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
Using the MT81w anti-mCD81 mAb, we first characterized the subpopulation of mCD81 that is associated with TEMs on the cell surface of Huh-7w7/mCD81 cells (Figure 3A). As shown by flow cytometry analysis, the intensity of MT81w labeling only reached 32 +/- 14%, depending on the experiment, of the intensity with MT81 in Huh-7w7/mCD81 cells, indicating that only a fraction of CD81 molecules is engaged in tetraspanin microdomains on these cells, as described for Hepa1-6 cells [23]. However, we cannot exclude that the lower affinity of MT81w may lead to an underestimate of the ratio of CD81 engaged in TEMs. The specificity of MT81w to recognize TEM-associated CD81 in Huh-7w7/mCD81 cells was confirmed by immunoprecipitation experiments from biotinylated cell lysates made under different detergent conditions. Tetraspanin microdomains are typically disrupted by Triton X-100, but are retained in less hydrophobic detergents such as Brij 97 [30]. As shown in Figure 3B, 5A6 and MT81 mAbs precipitated hCD81 and mCD81, respectively, under both detergent condition. In contrast, MT81w was able to precipitate mCD81 only from Brij97 lysates preserving tetraspanin-tetraspanin interactions, but not from Triton X-100 lysates. These results show that expression of mCD81 in Huh-7w7 cells allowed to reconstitute tetraspanin webs that are specifically recognized by the well characterized MT81w mAb [23].
###end p 27
###begin p 28
###xml 0 57 0 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Recognition of TEM-associated CD81 in Huh-7w7/mCD81 cells</bold>
###xml 59 60 59 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 144 145 144 145 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 240 241 240 241 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 374 375 374 375 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 485 486 485 486 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 646 647 646 647 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
Recognition of TEM-associated CD81 in Huh-7w7/mCD81 cells. A, Flow cytometry analysis of Huh-7w7/mCD81 cells stained with the mAbs MT81 and MT81w. Cells stained only with PE-conjugated secondary antibody were used as control (dotted line). B, Cell lines were surface biotinylated and lysed in the presence of Brij97 or Triton X-100 before immunoprecipitation with MT81, MT81w and 5A6 mAbs. Immunoprecipitates were revealed by western blotting using peroxidase-conjugated streptavidin. C, Cell lines were surface biotinylated and lysed in buffer containing 1% Brij97 and divalent ions. Immunoprecipitations were then performed with 5A6, MT81, MT81w, 8A12 (anti-EWI-2), TS151 (anti-CD151) or irrelevant (CTL) mAbs. Immunoprecipitates were revealed by western blotting using peroxidase-conjugated streptavidin. The molecular weights of the prestained molecular ladders are indicated in KDa. The asterisks indicate dimers of CD81.
###end p 28
###begin p 29
###xml 381 383 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 475 477 475 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 631 633 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 637 639 637 639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 725 727 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 774 776 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 807 808 807 808 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
###xml 1196 1198 1196 1198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3C</xref>
To ensure that similar molecular web interactions occur in Huh-7w7/mCD81 and Huh-7 cells, we next analyzed TEM composition in immunoprecipitation experiments of surface biotinylated cell lysates. Since lysis in Brij 97 preserves tetraspanin-tetraspanin interactions, any anti-tetraspanin mAb can co-immunoprecipitate the entire set of proteins present in tetraspanin microdomains [31]. The tetraspanin pattern obtained with Huh-7 cells using 5A6 hCD81 mAb is shown in Figure 3C. The major proteins co-immunoprecipitated with CD81 have an apparent molecular mass consistent with that of EWI-2 and EWI-F, two major partners of CD81 [30,32,33]. The identity of these proteins was confirmed by direct immunoprecipitation (Figure 3C and data not shown), as previously described [19]. Interestingly, MT81 and MT81w immunoprecipitations of mCD81 in Huh-7w7/mCD81 cells gave a pattern similar to that of hCD81 in Huh-7 cells (Figure 3C). EWI-2 and EWI-F proteins were co-immunoprecipitated with mCD81 in Huh-7w7/mCD81 cells. In addition, immunoprecipitation with an anti-CD151, another tetraspanin, co-immunoprecipitated a fraction of mCD81 in Huh-7w7/mCD81 cells as well as hCD81 in Huh-7 cells (Figure 3C, lines TS151). Altogether, in spite of slight differences in stoichiometry, these results show that mCD81 in Huh-7w7/mCD81 cells is engaged in similar web interactions than hCD81 in Huh-7 cells.
###end p 29
###begin p 30
###xml 45 46 45 46 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4A</xref>
###xml 114 116 114 116 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4B</xref>
###xml 384 385 383 384 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 588 589 586 587 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 649 651 647 649 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 839 840 836 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">4</xref>
###xml 874 875 871 872 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
We then analyzed the ability of MT81 and MT81w to inhibit HCVcc and HCVpp infectivity. As shown in Figures 4A and 4B, MT81 mAb, which recognizes the whole population of CD81, efficiently inhibited both HCVcc infection and HCVpp entry into Huh-7w7/mCD81 cells. Indeed, MT81 inhibited 80% of HCVcc infection and 95% of HCVpp infection at low concentrations (3 mug/ml). In contrast, MT81w was poorly neutralizing since it only induced an inhibition of 40% and 60% of HCVcc and HCVpp infection, respectively, at tenfold higher concentrations (30 mug/ml). However, it has to be noted that MT81w mAb might be a low-affinity antibody, as compared to MT81 [23]. The specificity of the observed inhibitory effect was ensured by using an irrelevant antibody at the highest concentration (anti-transferrin receptor antibody CD71 at 30 mug/ml, Figure 4 TR30). As expected, MT81 and MT81w did not affect HCVcc or HCVpp infectivity levels of Huh-7 cells (data not shown).
###end p 30
###begin p 31
###xml 56 57 56 57 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Neutralization assay of HCV infection with MT81 and MT81<underline>w</underline> antibodies</bold>
###xml 77 78 77 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 94 95 94 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 215 216 215 216 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 393 395 392 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 24 27 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Neutralization assay of HCV infection with MT81 and MT81w antibodies. HCVcc (A) and HCVpp 2a (B) infections of Huh-7w7/mCD81 cells were performed in presence of indicated concentrations of MT81 (left panels) or MT81w (right panels) mAbs or in presence of 30 mug/ml of transferrin receptor (right panels, TR30). At 2 days post-infection, cells were lysed and processed as described in methods. P < 0.05 as calculated by the Mann-Whitney's test.
###end p 31
###begin p 32
###xml 221 222 221 222 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 98 101 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 375 378 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Together, our results suggest that TEM-associated CD81 molecules might not play a central role in HCV entry. However, since we cannot exclude a partial recognition of TEM-associated CD81 molecules by the low affinity MT81w mAb or that the epitope recognized by this antibody is located outside of the E2 binding region, we further analyzed the role of TEM-associated CD81 in HCV entry using other approaches.
###end p 32
###begin title 33
###xml 23 26 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Role of cholesterol in HCV infection and the association of CD81 with TEM
###end title 33
###begin p 34
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 136 138 136 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 505 507 502 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 632 634 626 628 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5A</xref>
###xml 657 659 651 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5B</xref>
###xml 1087 1089 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5C</xref>
###xml 1094 1096 1082 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5D</xref>
###xml 1191 1193 1176 1178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 1275 1277 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5D</xref>
###xml 1436 1438 1418 1420 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1439 1441 1421 1423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 120 123 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 195 198 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 266 269 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 727 730 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1064 1067 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Cellular cholesterol has been shown to modulate the organization of tetraspanin microdomains [23] and to be involved in HCV life cycle [34]. To further analyze the role of TEM-associated CD81 in HCV infection, we next assessed the effect of cholesterol depletion on HCV infection. Huh-7w7/mCD81 cells were treated with increasing amounts of methyl-beta-cyclodextrin (MbetaCD), a cyclic oligosaccharide that selectively removes cholesterol from the plasma membrane without incorporating into the membrane [35]. Treatment of Huh-7w7/mCD81 cells with MbetaCD prior to infection resulted in a dose-dependent inhibition of HCVcc (Figure 5A) and HCVpp-2a (Figure 5B) infectivity. In both set of experiments the maximal inhibition of HCV infection was reached at an MbetaCD concentration of 15 mM, which decreased the cellular cholesterol content by fivefold (data not shown). Moreover, inhibition of infection was specifically due to cholesterol removal from the cell surface, since it was reversed by cholesterol replenishment with MbetaCD-cholesterol complexes before HCV infection (Figures 5C and 5D). Such preformed MbetaCD-cholesterol complexes are known to replenish cells with cholesterol [36]. It has to be noted that MbetaCD treatment had no effect on VSVpp entry (Figure 5D), which is clathrin dependent, indicating that HCVpp entry inhibition was not due to disruption of clathrin-enriched domains following cholesterol depletion [37-39]. In addition, cell treatment with MbetaCD at 15 mM three hours after cell/virus contact did not have any effect on infection (data not shown), indicating that membrane cholesterol is required at the entry step and MbetaCD is not toxic under our experimental conditions. Cholesterol depletion and replenishment experiments were performed on Huh-7 cells and gave similar results (data not shown).
###end p 34
###begin p 35
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Depletion of cellular cholesterol decreases HCV infection of Huh-7w7/mCD81 cells</bold>
###xml 191 192 188 189 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 207 208 204 205 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 555 557 543 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 44 47 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 653 656 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Depletion of cellular cholesterol decreases HCV infection of Huh-7w7/mCD81 cells. Huh-7w7/mCD81 cells were pretreated with increasing concentrations of MbetaCD prior to infection with HCVcc (A) or HCVpp 2a (B). Huh-7w7/mCD81 cells were untreated (NT) or pretreated with 7.5 mM of MbetaCD (MbetaCD) and then treated or not with 2.5 mM of preformed MbetaCD-Cholesterol complexes (Chol) (C and D). After treatment, cells were infected with HCVcc (C) or HCVpp-2a or VSVpp (D). At 2 days post-infection, cells were lysed and processed as described in methods. P < 0.05 as calculated by the Mann-Whitney's test; *, statistically not significant difference in HCV infectivity compared to infectivity in absence of drugs.
###end p 35
###begin p 36
###xml 56 59 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 192 195 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Altogether, our data confirm the role of cholesterol in HCV entry and bring to light a similar response of Huh-7w7/mCD81 and Huh-7 cells to cholesterol depletion and replenishment in terms of HCV infection.
###end p 36
###begin p 37
###xml 181 182 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6</xref>
###xml 332 335 321 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6Aa</xref>
###xml 598 601 587 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6Ac</xref>
###xml 779 781 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6B</xref>
###xml 1152 1153 1126 1127 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1162 1165 1136 1139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6Ab</xref>
###xml 1346 1349 1315 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6Af</xref>
###xml 1408 1411 1377 1380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6Ae</xref>
###xml 1553 1555 1522 1524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">6A</xref>
###xml 1557 1570 1526 1539 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">right panels)</bold>
###xml 574 577 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 886 889 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
We next analyzed by flow cytometry the surface expression of CD81 and its association with TEMs in Huh-7w7/mCD81 cells treated with MbetaCD or MbetaCD-cholesterol complexes (Figure 6), and expression of CD151 was used as a control (right panels). MbetaCD treatment of Huh-7w7/mCD81 cells reduced MT81 labelling by 58 +/- 7% (Figure 6Aa), suggesting that cholesterol depletion induced a decrease in total cell surface expression of mCD81 in Huh-7w7/mCD81 cells. Even with cholesterol replenishment, CD81 expression level could not be restored to conditions that would enable HCV infectivity (Figure 6Ac, MbetaCD+Chol). Incubation of MbetaCD-treated cells with increasing concentrations of preformed MbetaCD-cholesterol complexes raised cell surface mCD81 expression level (Figure 6B). However, a concentration four times higher than needed to reverse the inhibitory effect of MbetaCD on HCV infectivity (10 mM instead of 2,5 mM) was necessary to reach the cell surface mCD81 expression level of untreated cells. Interestingly, treatment with MbetaCD alone had no effect on TEM-associated mCD81 population in Huh-7w7/mCD81 cells, as determined using MT81w (Figure 6Ab). Conversely, cholesterol enrichment of non depleted cells with preformed MbetaCD-cholesterol complexes led to a 2 +/- 0.6 fold increase of TEM-associated mCD81 population (Figure 6Af), without any change in the total CD81 population (Figure 6Ae). These results confirm the role of cholesterol in TEM organization. Expression of CD151 under different conditions was not affected (Figure 6A, right panels).
###end p 37
###begin p 38
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cholesterol depletion affects total CD81 cell surface expression</bold>
###xml 66 67 66 67 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 482 483 461 462 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Cholesterol depletion affects total CD81 cell surface expression. A, Flow cytometry analysis of CD81 and CD151 expression on the cell surface of Huh-7w7/mCD81 cells. Upper panels: cells were treated with 7.5 mM of MbetaCD (MbetaCD) or left untreated (NT). Middle panels: cells were treated with 7.5 mM of MbetaCD (MbetaCD) followed by 2.5 mM of MbetaCD-Cholesterol (MbetaCD + Chol). Lower panels: cells were treated with 2.5 mM of MbetaCD-Cholesterol (Chol) or left untreated (NT). B, Cells were treated with 7.5 mM of MbetaCD (MbetaCD) followed by increasing concentrations (in mM) of MbetaCD-Cholesterol (MbetaCD + Chol) and total cell surface CD81 expression compared to untreated cells (NT) was measured using MT81 mAb.
###end p 38
###begin p 39
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 181 183 178 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 354 356 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
Our results differ from those of Silvie et al. showing that similar MbetaCD treatment of Hepa1-6 cells did not lead to a significant decrease of total CD81 cell surface expression [23]. However, it has to be noted that the tetraspanin CD9, expressed in Hepa1-6 cells but not in Huh-7 cells, has been shown to increase stability of tetraspanin complexes [40].
###end p 39
###begin p 40
###xml 83 86 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 248 251 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
In conclusion, cellular cholesterol depletion mediated by MbetaCD strongly affects HCV infection, but it has no effect on TEM-associated mCD81 in Huh-7w7/mCD81 cells. Again, these data do not support a key role for TEM-associated CD81 molecules in HCV infection.
###end p 40
###begin p 41
###xml 253 254 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 629 630 623 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 692 693 686 687 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1138 1139 1123 1124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 1295 1297 1277 1279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 1298 1300 1280 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 1301 1303 1283 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 1406 1408 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1409 1411 1388 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 55 58 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 119 122 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 242 245 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1478 1481 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Finally, we ensured that MbetaCD-induced inhibition of HCV entry did not lead to a reduced expression level of another HCV entry factor. We analyzed the expression levels of SR-BI, CLDN-1 and LDL receptor (LDL-R), three other major actors of HCV entry [9]. The tetraspanin CD151 was used again as a control. Since no antibody against extracellular loops of CLDN-1 is available for flow cytometry, we performed our analyses by immunoprecipitation of surface biotinylated cell lysates. As shown above, treatment of Huh-7w7/mCD81 cells with MbetaCD was accompanied by a reduced expression level of CD81, as detected by MT81 (Figure 7). We also found a reduced immunoprecipitation of CD81 by MT81w after MbetaCD treatment. Cholesterol depletion prior to lysis in Brij 97 likely led to a harsher effect of the detergent leading to a partial dissociation of tetraspanin complexes recognized by MT81w. Interestingly, treatment of Huh-7w7/mCD81 cells with MbetaCD did not lead to a reduction of cell surface expression of SR-BI, CLDN-1 or LDL-R. It has to be noted that SR-BI and CLDN-1 seemed even more expressed after MbetaCD treatment (Figure 7). This increased expression of SR-BI after MbetaCD treatment was confirmed by flow cytometry (data not shown) and has been previously described by others [24,41-43]. It has also been suggested that CLDN-1 might be in membrane domains resistant to MbetaCD treatment [44,45]. Altogether, our results show that MbetaCD-induced inhibition of HCV entry was solely due to reduced levels of cholesterol and CD81.
###end p 41
###begin p 42
###xml 0 110 0 110 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cholesterol depletion and ceramide enrichment do not reduce cell surface expression of other HCV entry factors</bold>
###xml 93 96 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Cholesterol depletion and ceramide enrichment do not reduce cell surface expression of other HCV entry factors. Huh-7w7/mCD81 cells were treated with 7.5 mM MbetaCD, with 0.5 unit Smase/ml or left untreated (NT) 30 min at 37degreesC. Cells were then surface biotinylated and lysed in buffer containing 1% Brij97 and divalent ions. Immunoprecipitations were performed with indicated mAbs. Immunoprecipitates were revealed by western blotting using peroxidase-conjugated streptavidin.
###end p 42
###begin title 43
###xml 47 50 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Role of ceramide in TEM-associated CD81 and in HCV infection
###end title 43
###begin p 44
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
###xml 514 516 514 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 971 973 971 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8A</xref>
###xml 449 452 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 590 593 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Beyond cholesterol, sphingolipids are also known to be important for the organization of the plasma membrane. Among them, sphingomyelin can be converted into ceramide by sphingomyelinase (Smase), and increasing ceramide concentration can lead to lipid microdomain reorganization [46]. We have previously reported that ceramide enrichment of the plasma membrane of Huh-7 cells following sphingomyelin hydrolysis by sphingomyelinase strongly inhibits HCV entry and reduces CD81 cell surface expression level by 50% [47]. Since sphingomyelin influences CD81 cell surface expression as well as HCV infection, we sought to determine the effect of the Smase treatment on TEM-associated CD81 population. Huh-7w7/mCD81 cells were pre-treated with Smase, washed and then infected with HCVcc or HCVpp-2a. Similarly to Huh-7 cells, Huh-7w7/mCD81 cells were affected by Smase treatment, resulting in 70-80% and 50-60% inhibition of HCVcc and HCVpp-2a infection, respectively (Figure 8A).
###end p 44
###begin p 45
###xml 0 128 0 128 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ceramide enrichment of the plasma membrane of Huh-7w7/mCD81 cells inhibits HCV entry and increases association of CD81 with TEMs</bold>
###xml 130 131 130 131 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 330 332 330 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P </italic>
###xml 381 382 381 382 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 492 493 492 493 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 75 78 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Ceramide enrichment of the plasma membrane of Huh-7w7/mCD81 cells inhibits HCV entry and increases association of CD81 with TEMs. A, Huh-7w7/mCD81 cells were pretreated (+Smase) or not (-Smase) with Smase prior to infection with HCVcc or HCVpp 2a. At 2 days post-infection, cells were lysed and processed as described in methods. P < 0.05 as calculated by the Mann-Whitney's test. B, Huh-7w7/mCD81 cells pretreated (+Smase) or not (-Smase) with Smase were stained with MT81 (left panel), MT81w (middle panel) or TS151 (right panel) mAbs. Cells stained only with PE-conjugated secondary antibody were used as control (dotted line).
###end p 45
###begin p 46
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8B</xref>
###xml 388 389 384 385 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 624 626 620 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8B</xref>
In order to determine whether these inhibitions were associated with changes in cell surface expression of CD81, we analyzed by flow cytometry the CD81 surface expression level after Smase treatment (Figure 8B). Interestingly, Smase treatment of Huh-7w7/mCD81 cells led to a significant reduction (52 +/- 18%) in MT81 labelling and conversely to significant increase (277 +/- 74%) in MT81w labelling, indicating that the treatment induced a reduction of total mCD81 expression and an increased association of CD81 with TEM. As expected, Smase treatment did not affect the expression of the control tetraspanin CD151 (Figure 8B).
###end p 46
###begin p 47
###xml 297 299 297 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8B</xref>
###xml 406 407 406 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">8B</xref>
###xml 525 526 525 526 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 674 675 674 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">7</xref>
###xml 49 52 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 124 127 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
We next ensured that Smase-induced inhibition of HCV entry was not also associated with reduced expression level of another HCV entry factor. As described above, we analyzed the expression levels of SR-BI, CLDN-1 and LDL-R after treatment of Huh-7w7/mCD81 cells with Smase. As shown above (Figure 8B), treatment with Smase was accompanied by a reduced expression level of CD81, as detected by MT81 (Figure 7). In accordance with our previous results (Figure 8B), we also found an increased immunoprecipitation of CD81 by MT81w after Smase treatment. Interestingly, expression level of SR-BI, CLDN-1 or LDL-R were not affected following treatment of cells with Smase (Figure 7).
###end p 47
###begin p 48
###xml 398 400 398 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 57 60 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 238 241 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Thus, Smase treatment of Huh-7w7/mCD81 cells resulted in HCV entry inhibition and increase of TEM-associated mCD81 population. In agreement with previous data, these results indicate that TEM-associated CD81 does not play a major role in HCV entry. Smase treatment resulted also in a significant decrease of cell surface expression of CD81 on Huh-7 cells (data not shown), as described previously [47]. The similarity of Huh-7 and Huh-7w7/mCD81 cells responses to Smase treatment tends to show that results obtained with Huh-7w7/mCD81 cells can be extrapolated to Huh-7 cells.
###end p 48
###begin title 49
Discussion and conclusion
###end title 49
###begin p 50
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 612 614 612 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 615 617 615 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B50">50</xref>
###xml 870 872 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 873 875 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B48">48</xref>
###xml 876 878 876 878 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B51">51</xref>
###xml 1086 1091 1086 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1271 1273 1271 1273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B52">52</xref>
###xml 1835 1837 1835 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 389 392 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 711 714 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 804 807 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 917 920 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1114 1117 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1207 1210 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1344 1347 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1423 1426 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1539 1542 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1746 1749 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
We have previously shown that mutations (CS-N6) in the structural proteins of the JFH-1 genome increase the production and infectivity of HCVcc particles, leading to an accelerated cytopathic effect [27]. Interestingly, infection of Huh-7 cells with such particles led us to isolate cellular clones exhibiting different levels of permissivity to HCVcc and HCVpp. For most of them, reduced HCV infection levels were directly related to their reduced expression level of CD81, while other entry molecules such as SR-BI and CLDN-1 were not modified. Our observation is in accordance with previously published data [29,48-50]. Ectopic expression of CD81 in Huh-7w7 cells, one of the resistant cell clones, restored HCV permissivity indicating that CD81 deficiency alone was responsible for the resistance to HCV infection in these cells. In agreement with previous studies [29,48,51], we did not observe any variation in HCV genome replication in Huh-7w7 cells in comparison to Huh-7 cells (data not shown), suggesting that CD81 is not involved in this step of the viral cycle. Masciopinto et al. showed that CD81 and HCV envelope glycoproteins could be detected in exosomes of mammalian cells, suggesting that HCV may intracellularly interact with CD81 allowing its export [52]. They pointed out a possible role of CD81 in assembly and release of HCV particles. However, our results indicate that CD81 does not participate to HCV assembly or release of new viral particles, since the supernatant of Huh-7w7 cells transfected with full-length HCV RNA infected naive Huh-7 cells to a level comparable to that of the supernatant from transfected Huh-7 cells. Thus, Huh-7w7 cells constitute a new tool allowing to investigate the involvement of CD81 in HCV entry and offering a new single-cycle replication system, as already used by others [29].
###end p 50
###begin p 51
###xml 130 132 130 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B53">53</xref>
###xml 151 157 151 157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al </italic>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 712 714 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 30 33 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 403 408 <span type="species:ncbi:9606">human</span>
###xml 413 418 <span type="species:ncbi:10090">mouse</span>
###xml 436 441 <span type="species:ncbi:9606">human</span>
###xml 782 785 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 837 840 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 999 1002 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The molecular determinants of HCV-CD81 interaction have been analyzed by several groups by using biochemical assays (reviewed in [53]). However, Flint et al have highlighted the limitation of these approaches since various mutated CD81 sequences previously reported to abrogate E2-CD81 interaction, were able to restore permissivity in HepG2 cells [15]. In our study, we show that ectopic expression of human and mouse CD81 proteins in human hepatoma cells devoid of CD81 conferred susceptibility to infection by HCVcc and HCVpp at various levels. Interestingly, mCD81 protein supports infection by HCVcc and HCVpp bearing glycoproteins from genotypes 2a and 4 suggesting that, in accordance with other studies [15,17], CD81 is not the sole determinant of species susceptibility to HCV. Other additional cellular factors likely modulate HCV entry. In addition, interaction/organization levels and stoichiometry between entry factors and plasma membrane lipids may regulate species susceptibility to HCV.
###end p 51
###begin p 52
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 573 575 573 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 943 945 943 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 1241 1242 1241 1242 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1330 1332 1330 1332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 1578 1579 1578 1579 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1675 1676 1675 1676 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 2134 2136 2134 2136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 2137 2139 2137 2139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 2140 2142 2140 2142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B54">54</xref>
###xml 2143 2145 2143 2145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B55">55</xref>
###xml 2224 2226 2224 2226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 2356 2357 2356 2357 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 2436 2437 2436 2437 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 2568 2570 2568 2570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 978 983 <span type="species:ncbi:9606">human</span>
###xml 1047 1050 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1118 1121 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1551 1554 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1692 1695 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1959 1962 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 2292 2295 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 2389 2392 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
CD81 belongs to the tetraspanin family of which members have the distinctive feature of clustering dynamically with numerous partner proteins and with one another in membrane microdomains. Within this web, the associations of tetraspanins with their nontetraspanin partner molecules have been referred to as primary, and tetraspanin can interact with each other through their associated partner [12]. In contrast to primary complexes, tetraspanin-tetraspanin interactions are not stoichiometric and palmitoylation is necessary for the maintenance of these interactions [28,40,54,55]. It is still unknown whether all tetraspanins expressed in a certain cell are associated with each other. Importantly, tetraspanins associate indirectly with additional proteins. Functionally, these interactions cluster in TEM, enabling lateral dynamic organization in the membrane and the cross-talk with intracellular signalling and cytoskeletal structures [21]. In our study, generation of a human cell line expressing mCD81 (Huh-7w7/mCD81 cells) permissive to HCV infection allowed us to analyze the role of TEM-associated CD81 in HCV infection. This study could be performed with two recently described mAbs: MT81, which recognizes total mCD81; and MT81w, which specifically recognizes a fraction of mCD81 associated with other tetraspanins [23]. It is worth noting that such a tool allowing the detection of hCD81 associated with TEMs is not available. We first determined the inhibitory effect of both mAbs on HCVcc and HCVpp infection: MT81 strongly inhibited HCV infection, whereas MT81w led to a weak inhibition of infection at saturing concentrations. This reduced capacity of MT81w mAb to inhibit HCV infection suggests that TEM-associated CD81 molecules, recognized by this mAb, are not the exclusive site of infection. In accordance with these results, ceramide enrichment of plasma membrane leading to an increased association of CD81 with TEMs highly inhibits HCV infection. While palmitoylation is not the only mechanism by which tetraspanins interact with each other, it has been shown to play an essential role in TEM organization [28,40,54,55]. The ability of palmitoylation-defective CD81 to support infection by HCVpp [10] is again consistent with a minor role of TEM-associated CD81 in HCV entry. We cannot exclude that the epitope recognized by MT81w mAb on CD81 is not involved in HCV interaction. The partial inhibition of MT81w might also be the reflect of a partial recognition of the TEM-associated CD81 fraction, as previously suggested by Silvie et al. [23].
###end p 52
###begin p 53
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 571 573 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B56">56</xref>
###xml 753 755 747 749 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
###xml 1201 1203 1195 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B57">57</xref>
###xml 1300 1301 1294 1295 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 1541 1543 1535 1537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B58">58</xref>
###xml 1544 1546 1538 1540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B59">59</xref>
###xml 1568 1569 1562 1563 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 11 14 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 176 179 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 286 289 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 497 500 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 738 741 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The entire HCV life cycle is associated with cholesterol metabolism in host cells (reviewed in [34]), and lipid composition of the plasma membrane seems very important for the HCV entry step. In our study, we showed that cholesterol depletion by treatment with MbetaCD strongly reduced HCV entry into target cells, and conversely cholesterol replenishment by MbetaCD-cholesterol complexes restored the infection levels. These results point out again the importance of cell membrane cholesterol in HCV entry, likely in the fusion process as has been previously suggested [56]. Very recently, we have shown that increasing the levels of ceramide in the plasma membrane induce a massive endocytosis of CD81 leading to a strong inhibition of HCV infection [47]. Interestingly, in the present study, we showed that following Smase treatment of Huh-7w7/mCD81 cells, expression of CD81 is inversely related to association of CD81 with tetraspanin webs. These results suggest that ceramide might specifically modify the levels of interaction or the cell surface distribution of TEM. In this regard, it has been shown that gangliosides play an important role in the organization of CD82-enriched microdomains [57]. Ceramide enrichment may also induce clustering of CD81 leading to an increased binding of MT81w mAb. In accordance with this hypothesis, it has been shown that high levels of ceramide induce large-scale clustering/capping of death receptors (e.g. Fas/CD95) required to initiate efficient formation of death-induced signalling complex [58,59]. Alternatively, MT81w may recognize an epitope of CD81 that is more exposed following ceramide enrichment. Further analyses are necessary to evaluate these hypotheses.
###end p 53
###begin p 54
###xml 8 19 8 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 156 158 156 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B60">60</xref>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B64">64</xref>
###xml 274 275 274 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B65">65</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 313 324 313 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 487 498 487 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Plasmodium </italic>
###xml 499 501 499 501 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 701 703 701 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B66">66</xref>
###xml 1218 1220 1218 1220 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 0 3 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 305 308 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 439 444 <span type="species:ncbi:10090">mouse</span>
###xml 721 724 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 1306 1309 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
HCV and Plasmodium are two major pathogens targeting the liver. Both use the glycosaminoglycans for their initial attachment on the surface of hepatocytes [11,60-64], and lipidic transfer properties of scavenger receptor class B type I regulate infection of both pathogens [9,65,66]. CD81 is required for HCV and Plasmodium life cycle. Antibodies to CD81 or CD81 silencing strongly reduce the infection of hepatic cells and CD81-deficient mouse hepatocytes are resistant to infection by Plasmodium [26]. Using CD81/CD9 chimeras, it has been recently shown that CD81 LEL plays a critical role in sporozoite infection and a stretch of 21 amino acids is sufficient to confer susceptibility to infection [66]. In contrast to HCV infection, it seems that CD81 does not act directly as a receptor but is rather involved indirectly, likely by modulating the activity of an associated protein. This hypothesis is supported by the fact that CD81 associated to multiple proteins in the tetraspanin web plays a major role in sporozoite infection, since modulation of cellular cholesterol levels, which changes tetraspanin microdomain organization, has been shown to also modify the extent of CD81-dependent sporozoite infection [23]. In contrast, in our study, we demonstrated that TEM-associated CD81 is not used by HCV, indicating that these two pathogens, while using the same molecules, invade their host by different mechanisms.
###end p 54
###begin title 55
Methods
###end title 55
###begin title 56
Antibodies
###end title 56
###begin p 57
###xml 123 124 123 124 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 487 490 487 490 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">488</sup>
###xml 57 60 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 502 506 <span type="species:ncbi:9925">goat</span>
###xml 512 517 <span type="species:ncbi:10090">mouse</span>
5A6 (anti-CD81 kindly provided by S. Levy); ACAP27 (anti-HCV core, kindly provided by JF Delagneau); MT81 (anti-CD81), MT81w (anti-TEM associated CD81), 8A12 (anti-EWI-2) and TS151 (anti-CD151) mAbs were used in this study. The anti-Claudin-1 (JAY.8) was from Zymed, the anti-SR-BI (NB400-104H3) was from Novus, the anti-LDL receptor was from Progen, the anti-transferrin receptor antibody was from Biolegend (Ozyme) and the anti-hCD81 (1.3.3.22) was from Santa Cruz Biotechnology. Alexa488-conjugated goat anti-mouse was from Jackson Immunoresearch.
###end p 57
###begin title 58
Production of HCVcc and infection assays
###end title 58
###begin p 59
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 104 112 104 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 333 335 333 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B67">67</xref>
###xml 652 660 640 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Renilla </italic>
###xml 197 201 <span type="species:ncbi:4530">Rice</span>
###xml 286 289 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
Production of HCVcc and infection assays were performed as described [19]. To generate HCVcc expressing Renilla luciferase, we used the FL-J6/JFH-5'C19Rluc2AUbi genome [67] kindly provided by C.M. Rice (The Rockfeller University, New York). We replaced the region encoding the J6/JFH-1 HCV polyprotein with the CS-N6 JFH-1 sequence [27]. HCVcc were produced as previously described [7,27,67]. HCVcc were added to Huh-7 cells seeded the day before and incubated for 2 h at 37degreesC. The supernatants were then removed and the cells were incubated in DMEM 10% FBS at 37degreesC. At 40-48 h post-infection, cells were lysed and processed to measure the Renilla luciferase activities as indicated by the manufacturer (Promega). Luciferase activities were normalized for protein concentration in each cell lysate. In each figure, results are reported as the mean +/- S.D. of three independent experiments.
###end p 59
###begin title 60
Generation of R1 cell population and resistant cellular clones
###end title 60
###begin p 61
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
Huh-7 cells were infected (m.o.i. = 1) with JFH-1/I2/CS-N6 particles [27] 4 h at 37degreesC and then maintained for several weeks. Survival cells were amplified and treated with 200 UI/ml of IFN alpha. After six successive treatments with IFN alpha, cells were analysed by immunofluorescence and western blotting and subcloned by limiting dilution. The cells were seeded in 96-well plates at 1 cell/well in DMEM 10% FCS. Individual cell clones were amplified and named Huh-7w with a number corresponding to the clone.
###end p 61
###begin title 62
Cell transfection
###end title 62
###begin p 63
###xml 143 145 143 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 113 119 <span type="species:ncbi:10090">murine</span>
Huh-7w7 cells were transfected using ExGen500 (Eurogentec) with plasmids expressing human CD81 (pcDNA3.1/hCD81), murine CD81 (pcDNA3.1/mCD81) [30] or the empty vector. Polyclonal populations were obtained by selection for 4 weeks with 600 mug/ml of Neomycin (Invitrogen).
###end p 63
###begin title 64
Antibody neutralization assay
###end title 64
###begin p 65
Neutralization assays were performed by co-incubating HCVcc/HCVpp and antibodies with target cells 3 h at 37degreesC. Cells were further incubated for 48 h with DMEM 10% FCS before measuring the luciferase activities.
###end p 65
###begin title 66
Cholesterol depletion/replenishment and sphingomyelinase (Smase) treatment
###end title 66
###begin p 67
###xml 629 631 605 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B47">47</xref>
Cholesterol depletion was carried out by incubating cells with different concentrations of methyl-beta-cyclodextrin (MbetaCD, Sigma) in serum-free medium at 37degreesC for 20 min. Cholesterol replenishment of cholesterol-depleted cells was achieved by incubating cells with 1:10 (mol/mol) complex of cholesterol and MbetaCD (cholesterol water soluble, Sigma) using a 2.5 mM final cholesterol concentration in serum-free medium at 37degreesC for 15 min. Cholesterol levels in MbetaCD-treated cells were determined using Amplex Red Cholesterol Assay kit (Molecular Probes). Smase treatments were performed as previously described [47].
###end p 67
###begin title 68
Production of HCVpp and infection assays
###end title 68
###begin p 69
###xml 45 46 45 46 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 47 49 47 49 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B68">68</xref>
###xml 331 333 331 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B69">69</xref>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B70">70</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B71">71</xref>
###xml 1153 1161 1153 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Firefly </italic>
###xml 163 166 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
###xml 567 593 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
###xml 613 642 <span type="species:ncbi:11767">feline endogenous virus RD114</span>
HCVpp were produced as described previously [3,68] with plasmids kindly provided by B. Bartosch and F.L. Cosset (INSERM U412, Lyon, France). The plasmids encoding HCV envelope glycoproteins of genotypes 1b (UKN1B-5.23), 2b (UKN2B-1.1), 3a (UKN3A-1.28) and 4 (UKN4-11.1) were kindly provided by J. Ball (Nottingham University, UK) [69]. The genotype 1a plasmid (strain H) has been described previously [3] and the genotype 2a plasmid (strain JFH-1) was kindly provided by T. Pietschmann and R. Bartenschlager (University of Heidelberg, Germany). Plasmids encoding the vesicular stomatitis virus glycoprotein G and feline endogenous virus RD114 glycoprotein [70] were used for the production of VSVpp and RD114pp, respectively. In each experiment, pseudotyped particles produced in the absence of envelope proteins were used as controls. The mean luminescence activity of such particles represented less than 2% of the activity measured for HCVpp. In cholesterol depletion and Smase experiments, particles were produced in DMEM containing 2% lipoprotein-depleted serum (LPDS) [71]. At 40-48 h post-infection, cells were lysed and processed to measure the Firefly luciferase activities as indicated by the manufacturer (Promega). Luciferase activities were normalized for protein concentration in each cell lysate. In each figure, results are reported as the mean +/- S.D. of three independent experiments.
###end p 69
###begin title 70
Detection of cell surface biotinylated proteins
###end title 70
###begin p 71
###xml 181 187 <span type="species:ncbi:9913">Bovine</span>
Cells were biotinylated with 0.2 mg/mL EZ-link-Sulfo-NHS-LC-biotin (Pierce) in Hanks buffered saline solution (Invitrogen) for 30 minutes at 4degreesC. After 3 rinses with PBS 0.6% Bovine Serum Albumin (BSA, Euromedex), cells were lysed in lysis buffer (1% Brij97 in D-PBS with Ca and Mg or 1% Triton X-100 in D-PBS with 2 mM EDTA) containing protease inhibitors (Complete, Roche). Lysates were precleared for 2 h at 4degreesC with protein A-sepharose (Amersham Biosciences), then incubated for 2 h at 4degreesC with specific mAbs immobilized onto protein A-sepharose beads. After rinsing with the lysis buffer, complexes were eluted with non-reducing Laemmli buffer, resolved by SDS-PAGE and immunoblotted with peroxidase-conjugated Streptavidin (Vector).
###end p 71
###begin title 72
Statistical analyses
###end title 72
###begin p 73
The Mann-Whitney's test, based on ranks, was used to compare the results to the reference. The reported p-values were asymptotic and two-sided. We considered a difference as significant for any p-value < 0.05. The tests were performed with the software SPSS 14.0.2.
###end p 73
###begin title 74
Flow cytometry analysis
###end title 74
###begin p 75
###xml 157 158 151 152 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</underline>
###xml 30 36 <span type="species:ncbi:9913">Bovine</span>
###xml 106 111 <span type="species:ncbi:9606">human</span>
###xml 134 140 <span type="species:ncbi:10090">murine</span>
###xml 168 173 <span type="species:ncbi:9606">human</span>
###xml 273 277 <span type="species:ncbi:9925">goat</span>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 297 300 <span type="species:ncbi:10116">rat</span>
Cells were rinsed with PBS 2% Bovine Serum Albumin (PBS/BSA) and incubated for 1 h at 4degreesC with anti-human CD81 (1.3.3.22), anti-murine CD81 (MT81, MT81w) or anti-human CD151 (TS151) mAbs. After rinsing with PBS/BSA, cells were stained with phycoerythrin (PE) labeled goat anti-mouse or anti-rat (BD Pharmingen) for 45 min at 4degreesC. After rinsing, cells were detached with PBS 2 mM EDTA and fixed with Formalin Solution (Sigma). Cells stained only with the secondary antibodies were used as negative control. Labelled cells were analyzed using a FACS Beckman EPICS-XL MCL.
###end p 75
###begin title 76
Authors' contributions
###end title 76
###begin p 77
VRP, ML, DD, JD, CW and LC conceived and designed the experiments. VRP, ML, DD, JC, AP, JP, CW and LC performed the experiments. CL performed the statistical analyses. ER, JD, CW and LC contributed to reagents/materials/analysis tools. VRP, ML and LC wrote the paper.
###end p 77
###begin title 78
Authors' information
###end title 78
###begin p 79
JD is an international scholar of the Howard Hughes Medical Institute.
###end p 79
###begin title 80
Acknowledgements
###end title 80
###begin p 81
###xml 306 310 <span type="species:ncbi:4530">Rice</span>
We thank Sophana Ung and Valentina D'Arienzo for their technical assistance. We thank Birke A. Tews, Kevin Friede and Francois Helle for critical reading of the manuscript. We are grateful to S. Levy, T. Wakita, J-F. Delagneau, F-L. Cosset, B. Bartosch, R. Bartenschlager, T. Pietschmann, J. Ball and C.M. Rice for providing us with reagents. We thank the Microscopy-Imaging-Cytometry Platform of the Lille Pasteur Campus for access to the instruments and technical advice. This work was supported by the "Institut Federatif de Recherche-142" (IFR142) and by grants from the CNRS and the "Agence Nationale de Recherches sur le Sida et les hepatites virales" ANRS. VRP was supported by a fellowship from the "Institut Pasteur de Lille/Region Nord Pas-de-Calais". ML and DD were supported by a fellowship from the ANRS. JC was supported by the Pasteur Institute of Lille and the University of Florida.
###end p 81
###begin article-title 82
###xml 0 11 <span type="species:ncbi:11103">Hepatitis C</span>
Hepatitis C Virus
###end article-title 82
###begin article-title 83
###xml 15 26 <span type="species:ncbi:11103">hepatitis C</span>
Treating viral hepatitis C: efficacy, side effects, and complications
###end article-title 83
###begin article-title 84
###xml 18 29 <span type="species:ncbi:11103">hepatitis C</span>
Highly infectious hepatitis C pseudo-viruses containing functional E1E2 envelope protein complexes
###end article-title 84
###begin article-title 85
###xml 38 55 <span type="species:ncbi:11103">hepatitis C virus</span>
Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins
###end article-title 85
###begin article-title 86
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles
###end article-title 86
###begin article-title 87
###xml 24 41 <span type="species:ncbi:11103">hepatitis C virus</span>
Complete replication of hepatitis C virus in cell culture
###end article-title 87
###begin article-title 88
###xml 25 42 <span type="species:ncbi:11103">hepatitis C virus</span>
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
###end article-title 88
###begin article-title 89
###xml 7 24 <span type="species:ncbi:11103">hepatitis C virus</span>
Robust hepatitis C virus infection in vitro
###end article-title 89
###begin article-title 90
###xml 19 36 <span type="species:ncbi:11103">hepatitis C virus</span>
Early steps of the hepatitis C virus life cycle
###end article-title 90
###begin article-title 91
###xml 53 70 <span type="species:ncbi:11103">hepatitis C virus</span>
Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry
###end article-title 91
###begin article-title 92
###xml 39 56 <span type="species:ncbi:11103">hepatitis C virus</span>
Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses
###end article-title 92
###begin article-title 93
Tetraspanins
###end article-title 93
###begin article-title 94
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
###xml 55 63 <span type="species:ncbi:9491">tamarins</span>
Hepatitis C virus envelope protein E2 binds to CD81 of tamarins
###end article-title 94
###begin article-title 95
###xml 20 37 <span type="species:ncbi:11103">hepatitis C virus</span>
Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
###end article-title 95
###begin article-title 96
###xml 30 47 <span type="species:ncbi:11103">hepatitis C virus</span>
Diverse CD81 proteins support hepatitis C virus infection
###end article-title 96
###begin article-title 97
###xml 76 93 <span type="species:ncbi:11103">hepatitis C virus</span>
Identification of amino acid residues in CD81 critical for interaction with hepatitis C virus envelope glycoprotein E2
###end article-title 97
###begin article-title 98
###xml 14 19 <span type="species:ncbi:9606">human</span>
###xml 28 43 <span type="species:ncbi:10090">transgenic mice</span>
###xml 78 95 <span type="species:ncbi:11103">hepatitis C virus</span>
Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection
###end article-title 98
###begin article-title 99
###xml 11 28 <span type="species:ncbi:11103">hepatitis C virus</span>
Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection
###end article-title 99
###begin article-title 100
###xml 36 53 <span type="species:ncbi:11103">hepatitis C virus</span>
The CD81 partner EWI-2wint inhibits hepatitis C virus entry
###end article-title 100
###begin article-title 101
The tetraspanin web modulates immune-signalling complexes
###end article-title 101
###begin article-title 102
Protein-protein interactions in the tetraspanin web
###end article-title 102
###begin article-title 103
CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins
###end article-title 103
###begin article-title 104
Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites
###end article-title 104
###begin article-title 105
###xml 14 25 <span type="species:ncbi:11103">Hepatitis C</span>
Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B Type I
###end article-title 105
###begin article-title 106
###xml 14 19 <span type="species:ncbi:9606">human</span>
Expression of human CD81 differently affects host cell susceptibility to malaria sporozoites depending on the Plasmodium species
###end article-title 106
###begin article-title 107
###xml 32 53 <span type="species:ncbi:5833">Plasmodium falciparum</span>
###xml 58 75 <span type="species:ncbi:5861">Plasmodium yoelii</span>
Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity
###end article-title 107
###begin article-title 108
###xml 91 108 <span type="species:ncbi:11103">hepatitis C virus</span>
Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins
###end article-title 108
###begin article-title 109
Contrasting effects of EWI proteins, integrins, and protein palmitoylation on cell surface CD9 organization
###end article-title 109
###begin article-title 110
###xml 90 107 <span type="species:ncbi:11103">hepatitis C virus</span>
Advantages of a single-cycle production assay to study cell culture-adaptive mutations of hepatitis C virus
###end article-title 110
###begin article-title 111
EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells
###end article-title 111
###begin article-title 112
Multiple levels of interactions within the tetraspanin web
###end article-title 112
###begin article-title 113
The major CD9 and CD81 molecular partner. Identification and characterization of the complexes
###end article-title 113
###begin article-title 114
EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily
###end article-title 114
###begin article-title 115
###xml 70 87 <span type="species:ncbi:11103">hepatitis C virus</span>
Reliance of host cholesterol metabolic pathways for the life cycle of hepatitis C virus
###end article-title 115
###begin article-title 116
Cellular cholesterol efflux mediated by cyclodextrins. Demonstration Of kinetic pools and mechanism of efflux
###end article-title 116
###begin article-title 117
Use of cyclodextrins for manipulating cellular cholesterol content
###end article-title 117
###begin article-title 118
Plasma membrane microdomains: organization, function and trafficking
###end article-title 118
###begin article-title 119
Where sterols are required for endocytosis
###end article-title 119
###begin article-title 120
###xml 45 71 <span type="species:ncbi:11276">vesicular stomatitis virus</span>
Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells
###end article-title 120
###begin article-title 121
Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation
###end article-title 121
###begin article-title 122
Cellular cholesterol regulates expression of the macrophage type B scavenger receptor, CD36
###end article-title 122
###begin article-title 123
Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools
###end article-title 123
###begin article-title 124
Sterol regulation of scavenger receptor class B type I in macrophages
###end article-title 124
###begin article-title 125
Depletion of Caco-2 cell cholesterol disrupts barrier function by altering the detergent solubility and distribution of specific tight-junction proteins
###end article-title 125
###begin article-title 126
Methyl-beta-cyclodextrin increases permeability of Caco-2 cell monolayers by displacing specific claudins from cholesterol rich domains associated with tight junctions
###end article-title 126
###begin article-title 127
Ceramide-enriched membrane domains
###end article-title 127
###begin article-title 128
###xml 85 102 <span type="species:ncbi:11103">hepatitis C virus</span>
Ceramide enrichment of the plasma membrane induces CD81 internalization and inhibits hepatitis C virus entry
###end article-title 128
###begin article-title 129
###xml 90 107 <span type="species:ncbi:11103">hepatitis C virus</span>
CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection
###end article-title 129
###begin article-title 130
###xml 48 65 <span type="species:ncbi:11103">hepatitis C virus</span>
Superinfection exclusion in cells infected with hepatitis C virus
###end article-title 130
###begin article-title 131
###xml 11 28 <span type="species:ncbi:11103">hepatitis C virus</span>
Persistent hepatitis C virus infection in vitro: coevolution of virus and host
###end article-title 131
###begin article-title 132
###xml 87 104 <span type="species:ncbi:11103">hepatitis C virus</span>
The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells
###end article-title 132
###begin article-title 133
###xml 15 32 <span type="species:ncbi:11103">hepatitis C virus</span>
Association of hepatitis C virus envelope proteins with exosomes
###end article-title 133
###begin article-title 134
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus entry into host cells
###end article-title 134
###begin article-title 135
Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling
###end article-title 135
###begin article-title 136
Palmitoylation of tetraspanin proteins: modulation of CD151 lateral interactions, subcellular distribution, and integrin-dependent cell morphology
###end article-title 136
###begin article-title 137
###xml 0 17 <span type="species:ncbi:11103">Hepatitis C virus</span>
Hepatitis C virus glycoproteins mediate low pH-dependent membrane fusion with liposomes
###end article-title 137
###begin article-title 138
Gangliosides play an important role in the organization of CD82-enriched microdomains
###end article-title 138
###begin article-title 139
Ceramide enables fas to cap and kill
###end article-title 139
###begin article-title 140
Ceramide-mediated clustering is required for CD95-DISC formation
###end article-title 140
###begin article-title 141
###xml 39 56 <span type="species:ncbi:11103">hepatitis C virus</span>
Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction
###end article-title 141
###begin article-title 142
###xml 39 56 <span type="species:ncbi:11103">hepatitis C virus</span>
Sulfated homologues of heparin inhibit hepatitis C virus entry into mammalian cells
###end article-title 142
###begin article-title 143
Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes
###end article-title 143
###begin article-title 144
###xml 84 87 <span type="species:ncbi:11103?0.9633797444211329">HCV</span>
The roles of CD81 and glycosaminoglycans in the adsorption and uptake of infectious HCV particles
###end article-title 144
###begin article-title 145
Malaria sporozoites and circumsporozoite proteins bind specifically to sulfated glycoconjugates
###end article-title 145
###begin article-title 146
Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection
###end article-title 146
###begin article-title 147
Hepatocyte permissiveness to Plasmodium infection is conveyed by a short and structurally conserved region of the CD81 large extracellular domain
###end article-title 147
###begin article-title 148
###xml 46 63 <span type="species:ncbi:11103">hepatitis C virus</span>
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry
###end article-title 148
###begin article-title 149
###xml 31 48 <span type="species:ncbi:11103">hepatitis C virus</span>
Characterization of functional hepatitis C virus envelope glycoproteins
###end article-title 149
###begin article-title 150
###xml 96 113 <span type="species:ncbi:11103">hepatitis C virus</span>
Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus
###end article-title 150
###begin article-title 151
###xml 187 192 <span type="species:ncbi:9606">human</span>
Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates
###end article-title 151
###begin article-title 152
Practical methods for plasma lipoprotein analysis
###end article-title 152

